oai:ojs2.biosight.org:article/1The purpose of this study was to determine neurotransmitter and vitamin D3 levels in both men and women. Fifty healthy middle-aged men and women of 41.17 ± 9.6 and 42 ± 9.59 years respectively were selected. They have no known disease. While 50 male and female diabetic patients with an average age of 55.5 ± 14.92 and 47.87 ± 10.81 years were selected respectively. Anthropological data, including age, weight and length, were recorded in both controls and patients. To test the hypothesis of study relationship between vitamin D and neurotransmitters was analyzed in both groups. The statistical significance was taken at the p-level <0.05. The diabetic patients had neuropathy for 3 to 5 years with high HbA1c. Age and gender do not significantly affect neuropathy in diabetes. The average standard deviation of vitamin D3 is significantly lower in those having diabetic neuropathies, 12,448 ± 3,519 ng / ml (SD), which is not 24,958 ± 5,419 ng / ml, and was compared with vitamin D3 neuropathy in patients who did not have diabetes. (p <0.01). This analysis has shown that the neuropathy of diabetes is strongly linked to vitamin D3 after including confusion such as "Duration of diabetes and HbA1c". In patients with diabetes, the effects of vitamin D3 on neuropathy and the need for further studies ensure that there is a delay in preventing the dose of vitamin D3 or in the onset of neuropathy due to diabete
